Agios (AGIO) Q3 2026 Earnings Call Transcript
Third-quarter thalassemia launch sales topped all of 2025 revenue
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Finance & Markets
Arista Networks vs. ServiceNow: Which Technology Stock Is a Better Buy for 2027?
Arista's near-zero debt and 39% net margin stand in sharp contrast to ServiceNow's cheaper valuation, and the gap between them may decide which stock deserves your capital.
- Arista Networks reported $9.0 billion revenue in 2025, 28.6% increase YoY
- ServiceNow generated $13.3 billion revenue in 2025, 13.2% net margin
- ServiceNow shares volatile in 2026 due to generative AI concerns
Festive season crackdown: Maharashtra FDA seizes food stock worth ₹63.45 crore
According to a press note issued by the FDA, officials inspected 9,667 food establishments across Maharashtra, issued 4,603 improvement notices and initiated action to cancel 25 licences and…
TikTok launches standalone TikTok Shop app (in four markets)
TikTok has launched a standalone TikTok Shop app in Singapore, Malaysia, Thailand, and the Philippines, offering product videos and app-exclusive deals.
SpaceX and Tesla Stock Plunges Have Wiped About $450 Billion in Value Since the Midterms. Is It Time to Buy?
Elon Musk's two public companies have lost about $450 billion in market value in just two trading days. Here's what's behind the selloff, and whether either stock is worth buying now.
- SpaceX and Tesla stocks lost $450 billion in value since midterms.
- Tesla's stock fell from $398.50 to $342, SpaceX's from $141.31 to $125.
- SpaceX remains profitable with $2.79 billion operating income.
US Physical Therapy (USPH) Q3 2026 Earnings Call Transcript
Hospital affiliations surged, but rising insurance costs tested margins this quarter.
Am Superconductor (AMSC) Q2 2026 Earnings Call Transcript
Record collections boosted cash flow, but Q3 project timing looks challenging